Présentation : Vétoquinol specializes in the research, development, production and marketing of veterinary drugs and products for livestock (51.9% of net sales; cattle, pigs, poultry, etc.) and pets (48.1%; dogs, cats, etc.).
Net sales break down by product family as follows:
- antibiotics (45%);
- anti-inflammatories (13%);
- cardiology and nephrology treatments (2%);
- other (38%): anti-parasitics, vaccines, and nutritional products.
At the end of 2010, the group had six production sites located in France (2), Poland (2), Italy and Canada.
Net sales are distributed geographically as follows: Europe (64.7%), Americas (24%) and other (11.3%).
